» Articles » PMID: 35807211

Pathway Dependence of the Formation and Development of Prefibrillar Aggregates in Insulin B Chain

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Jul 9
PMID 35807211
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloid fibrils have been an important subject as they are involved in the development of many amyloidoses and neurodegenerative diseases. The formation of amyloid fibrils is typically initiated by nucleation, whereas its exact mechanisms are largely unknown. With this situation, we have previously identified prefibrillar aggregates in the formation of insulin B chain amyloid fibrils, which have provided an insight into the mechanisms of protein assembly involved in nucleation. Here, we have investigated the formation of insulin B chain amyloid fibrils under different pH conditions to better understand amyloid nucleation mediated by prefibrillar aggregates. The B chain showed strong propensity to form amyloid fibrils over a wide pH range, and prefibrillar aggregates were formed under all examined conditions. In particular, different structures of amyloid fibrils were found at pH 5.2 and pH 8.7, making it possible to compare different pathways. Detailed investigations at pH 5.2 in comparison with those at pH 8.7 have suggested that the evolution of protofibril-like aggregates is a common mechanism. In addition, different processes of evolution of the prefibrillar aggregates have also been identified, suggesting that the nucleation processes diversify depending on the polymorphism of amyloid fibrils.

Citing Articles

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics.

Arar S, Haque M, Kayed R Proteins. 2023; .

PMID: 37530227 PMC: 10834863. DOI: 10.1002/prot.26561.

References
1.
Yamamoto N, Tsuhara S, Tamura A, Chatani E . A specific form of prefibrillar aggregates that functions as a precursor of amyloid nucleation. Sci Rep. 2018; 8(1):62. PMC: 5758805. DOI: 10.1038/s41598-017-18390-y. View

2.
Fitzpatrick A, Falcon B, He S, Murzin A, Murshudov G, Garringer H . Cryo-EM structures of tau filaments from Alzheimer's disease. Nature. 2017; 547(7662):185-190. PMC: 5552202. DOI: 10.1038/nature23002. View

3.
Laganowsky A, Liu C, Sawaya M, Whitelegge J, Park J, Zhao M . Atomic view of a toxic amyloid small oligomer. Science. 2012; 335(6073):1228-31. PMC: 3959867. DOI: 10.1126/science.1213151. View

4.
Chiricotto M, Melchionna S, Derreumaux P, Sterpone F . Hydrodynamic effects on β-amyloid (16-22) peptide aggregation. J Chem Phys. 2016; 145(3):035102. DOI: 10.1063/1.4958323. View

5.
Erdemir D, Lee A, Myerson A . Nucleation of crystals from solution: classical and two-step models. Acc Chem Res. 2009; 42(5):621-9. DOI: 10.1021/ar800217x. View